Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes

    ... (MDS) become transfusion-dependent and are at risk for red blood cell (RBC) alloimmunization. This study compared alloimmunization ...

    Research Article last updated 02/03/2017 - 11:00am.

  2. Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate

    ... underlying disease process in MDS and frequent use of red blood cell transfusions lead to iron accumulation and ultimately organ ...

    Research Article last updated 01/26/2017 - 10:17am.

  3. Debby Cook, Feeling at home in the muddy water

    ... when I was no longer neutropenic (low number of white blood cells), we were out for lunch and I saw a sign for a yoga studio.  I ... that I get to be his mom. Today I feel good.  My red blood cell counts, white blood cell counts and platelets are ...

    Patient Chronicle last updated 09/11/2017 - 8:30am.

  4. Strong results for SAA patients at Johns Hopkins

    ... regimen, published online Dec. 22, 2016, in Biology of Blood and Marrow Transplantation, the Johns Hopkins team says that more than a ... bone marrow cells, which gradually stop producing red and white blood cells and platelets. Patients must receive frequent ...

    Article last updated 02/07/2017 - 11:05am.

  5. MDS expert finds promising antibody

    ... Researchers find new way to target blood stem cell cancers Article Source:  ... of leukemic stem cells become incapable of maturing into red or white blood cells as intended. Most leukemias respond initially to ...

    Article last updated 01/26/2017 - 1:14pm.

  6. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

    ... aim of treatment is to improve anemia and decrease red blood cell transfusions. For transfusion-dependent patients with lower-risk ...

    Research Article last updated 12/09/2016 - 2:50pm.

  7. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    Journal Title:  Biol Blood Marrow Transplant Primary Author:  ... for 3 consecutive days was 19 (range, 16 to 27) days, to red cell engraftment was 25 (range, 2 to 58) days, and to last ...

    Research Article last updated 01/24/2017 - 10:04am.

  8. Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

    ... Lenalidomide could effectively induce red blood cell (RBC) transfusion independence (TI) in patients with ...

    Research Article last updated 11/28/2016 - 9:36am.

  9. Local TV covers AAMDSIF Peer Support Networker

    ... characterized the complement system destructing red blood cells to early. Red blood cells are missing the PIG-A gene that ...

    Article last updated 11/28/2016 - 3:21pm.

  10. Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed

    ... Journal Title:  Indian J Hematol Blood Transfus Primary Author:  ... of complement-mediated hemolysis in unprotected red cells, leukocytes, and platelets as well as the release of free ...

    Research Article last updated 11/28/2016 - 11:40am.